1256P Capmatinib safety update in MET dysregulated NSCLC from the GEOMETRY mono-1 trial

Title
1256P Capmatinib safety update in MET dysregulated NSCLC from the GEOMETRY mono-1 trial
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 32, Issue -, Pages S986-S987
Publisher
Elsevier BV
Online
2021-09-22
DOI
10.1016/j.annonc.2021.08.1859

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now